BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37382881)

  • 1. Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function.
    Chen J; Zhang X; Tan X; Liu P
    J Exp Med; 2023 Oct; 220(10):. PubMed ID: 37382881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.
    Jaiswal BS; Janakiraman V; Kljavin NM; Chaudhuri S; Stern HM; Wang W; Kan Z; Dbouk HA; Peters BA; Waring P; Dela Vega T; Kenski DM; Bowman KK; Lorenzo M; Li H; Wu J; Modrusan Z; Stinson J; Eby M; Yue P; Kaminker JS; de Sauvage FJ; Backer JM; Seshagiri S
    Cancer Cell; 2009 Dec; 16(6):463-74. PubMed ID: 19962665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.
    Davis RJ; Gönen M; Margineantu DH; Handeli S; Swanger J; Hoellerbauer P; Paddison PJ; Gu H; Raftery D; Grim JE; Hockenbery DM; Margolin AA; Clurman BE
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5462-5467. PubMed ID: 29735700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA DBH-AS1 promotes cancer progression in diffuse large B-cell lymphoma by targeting FN1 via RNA-binding protein BUD13.
    Song Y; Gao F; Peng Y; Yang X
    Cell Biol Int; 2020 Jun; 44(6):1331-1340. PubMed ID: 32091157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer.
    Grim JE; Knoblaugh SE; Guthrie KA; Hagar A; Swanger J; Hespelt J; Delrow JJ; Small T; Grady WM; Nakayama KI; Clurman BE
    Mol Cell Biol; 2012 Jun; 32(11):2160-7. PubMed ID: 22473991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations.
    Thirimanne HN; Wu F; Janssens DH; Swanger J; Diab A; Feldman HM; Amezquita RA; Gottardo R; Paddison PJ; Henikoff S; Clurman BE
    Elife; 2022 Feb; 11():. PubMed ID: 35225231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells.
    Liu M; Ruan X; Liu X; Dong W; Wang D; Yang C; Liu L; Wang P; Zhang M; Xue Y
    Cell Death Dis; 2022 Dec; 13(12):1017. PubMed ID: 36463205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal Somatic Mutations in Cancer Transformation.
    Wijewardhane N; Dressler L; Ciccarelli FD
    Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis.
    Zhao L; Sun T; Pei J; Ouyang Q
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4046-54. PubMed ID: 26170328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of BUD13 in the prognosis of hepatocellular carcinoma revealed by pan-cancer analysis.
    He H; Qiu Z
    Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):41-48. PubMed ID: 37605593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating Fbw7 on the road to cancer.
    Xu W; Taranets L; Popov N
    Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNASEH1-AS1 induced by H3K27ac stabilizes ANXA2 mRNA to promote the progression of colorectal cancer through recruiting BUD13.
    Zhuang S; Lu W; Shen L; Huang Z; Zhang X; Zhang Y
    Neoplasma; 2023 Oct; 70(5):597-609. PubMed ID: 38053379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
    Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
    Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.
    Vaughan CA; Singh S; Grossman SR; Windle B; Deb SP; Deb S
    Mol Oncol; 2017 Jun; 11(6):696-711. PubMed ID: 28423230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
    Kämpjärvi K; Kim NH; Keskitalo S; Clark AD; von Nandelstadh P; Turunen M; Heikkinen T; Park MJ; Mäkinen N; Kivinummi K; Lintula S; Hotakainen K; Nevanlinna H; Hokland P; Böhling T; Bützow R; Böhm J; Mecklin JP; Järvinen H; Kontro M; Visakorpi T; Taipale J; Varjosalo M; Boyer TG; Vahteristo P
    Prostate; 2016 Jan; 76(1):22-31. PubMed ID: 26383637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype.
    McMurray HR; Sampson ER; Compitello G; Kinsey C; Newman L; Smith B; Chen SR; Klebanov L; Salzman P; Yakovlev A; Land H
    Nature; 2008 Jun; 453(7198):1112-6. PubMed ID: 18500333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer.
    Bielski CM; Donoghue MTA; Gadiya M; Hanrahan AJ; Won HH; Chang MT; Jonsson P; Penson AV; Gorelick A; Harris C; Schram AM; Syed A; Zehir A; Chapman PB; Hyman DM; Solit DB; Shannon K; Chandarlapaty S; Berger MF; Taylor BS
    Cancer Cell; 2018 Nov; 34(5):852-862.e4. PubMed ID: 30393068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis.
    Yue X; Wu F; Li Y; Liu J; Boateng M; Mandava K; Zhang C; Feng Z; Gao J; Hu W
    Cell Cycle; 2020 Jun; 19(11):1338-1351. PubMed ID: 32275841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual regulation of Fbw7 function and oncogenic transformation by Usp28.
    Schülein-Völk C; Wolf E; Zhu J; Xu W; Taranets L; Hellmann A; Jänicke LA; Diefenbacher ME; Behrens A; Eilers M; Popov N
    Cell Rep; 2014 Nov; 9(3):1099-109. PubMed ID: 25437563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.